| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |